Nutritional High to Enter Cannabis Drink Market With Xanthic Biopharma Ltd.
Nov 08, 2017 12:30 pm UTC| Business
TORONTO, Nov. 08, 2017 -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to announce that it has entered into an agreement with Xanthic...
Perrier® Tests National Ad Campaign on Provision’s 3D Savings Center
Nov 08, 2017 12:30 pm UTC| Business
CHATSWORTH, Calif., Nov. 08, 2017 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that Perrier® Sparkling Mineral Water (“Perrier”) will...
Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 08, 2017 12:30 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial...
Pure Energy Minerals Announces Further Expansion of Clayton Valley Lithium Project
Nov 08, 2017 12:30 pm UTC| Business
DENVER, Nov. 08, 2017 -- Pure Energy Minerals Limited (TSX VENTURE:PE) (OTCQB:PEMIF) (the “Company” or “Pure Energy”) is pleased to announce that it has entered into an asset purchase agreement (the “Agreement”) with...
Nov 08, 2017 12:16 pm UTC| Business
Palo Alto, CA, Nov. 08, 2017 -- Palo Alto, CA: PARC, a Xerox company, today announced it has accepted an award by the U.S. Department of Energy’s Office of Electricity Delivery and ENergy Reliability (OE) to develop,...
Huntington Ingalls Industries Reports Third Quarter 2017 Results
Nov 08, 2017 12:15 pm UTC| Business
Revenues were $1.86 billionOperating margin was 12.7% Segment operating margin was 10.3%Diluted earnings per share was $3.27Cash from operations was $96 million; free cash flow was $5 million NEWPORT NEWS, Va., Nov. 08,...
Nov 08, 2017 12:05 pm UTC| Business
HALIFAX, Nova Scotia, Nov. 08, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immuno-oncology company, today announced that Health Canada has granted Sunnybrook Research Institute...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update